Novel polypeptides homologous to thymosin, ephrin a, receptors, and fibromodulin, and polynucleotides encoding same
CA 2425302 A1 · Owner: Curagen Corporation · Inventors: Bandaru, Raj; Taupier, Raymond J.; Prayaga, Sudhirdas K.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Disclosed herein are novel human nucleic acid sequences that have homology to thymosin, ephrin A receptors, proteoglycans and fibromodulin. Also disclosed are polypeptides encoded by these nucleic acid sequences and antibodies which , immunospecifically-bind to the polypeptide as well as derivatives, variants, mutants or fragments of the aforementioned polypeptide polynucleotide, or , antibody. The invention further discloses therapeutic diagnostic and research , methods for diagnosis treatment, and prevention of disorders involving these novel nucleic acids and proteins.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed October 10, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended October 10, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 10, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.